View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsOsmozis 配当と自社株買い配当金 基準チェック /06Osmozis配当金を支払った記録がありません。主要情報n/a配当利回り-15.1%バイバック利回り総株主利回り-15.1%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesNew Risk • Jun 11New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.6% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€43.0m market cap, or US$46.2m).New Risk • May 30New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 54% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks High level of debt (54% net debt to equity). Profit margins are more than 30% lower than last year (6.7% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€42.9m market cap, or US$46.4m).New Risk • May 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.5% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€42.3m market cap, or US$45.9m).Reported Earnings • Jan 02Full year 2023 earnings released: EPS: €0.29 (vs €0.47 in FY 2022)Full year 2023 results: EPS: €0.29 (down from €0.47 in FY 2022). Revenue: €13.2m (up 14% from FY 2022). Net income: €701.7k (down 30% from FY 2022). Profit margin: 5.3% (down from 8.7% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.New Risk • Dec 26New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended February 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks High level of debt (150% net debt to equity). Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Shareholders have been diluted in the past year (34% increase in shares outstanding). Market cap is less than US$100m (€31.4m market cap, or US$34.6m).お知らせ • Oct 13Osmozis SA (ENXTPA:ALOSM) acquired Campingconnect Ltd.Osmozis SA (ENXTPA:ALOSM) acquired Campingconnect Ltd on October 11, 2023.Osmozis SA (ENXTPA:ALOSM) completed the acquisition of Campingconnect Ltd on October 11, 2023.分析記事 • Sep 16There's Been No Shortage Of Growth Recently For Osmozis' (EPA:ALOSM) Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...Reported Earnings • Dec 17Full year 2022 earnings releasedFull year 2022 results: Revenue: €11.6m (up 21% from FY 2021). Net income: €1.01m (up 1.7% from FY 2021). Profit margin: 8.7% (down from 10% in FY 2021). The decrease in margin was driven by higher expenses.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Assistant CEO, Director & Co-Founder Yves Boulot was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Sep 22Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €7.64, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 21x in the Communications industry in France. Total loss to shareholders of 21% over the past three years.Price Target Changed • Apr 27Price target increased to €9.50Up from €8.30, the current price target is provided by 1 analyst. New target price is 18% above last closing price of €8.06. Stock is up 55% over the past year. The company is forecast to post earnings per share of €1.17 for next year compared to €0.46 last year.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Assistant CEO, Director & Co-Founder Yves Boulot was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.分析記事 • Jan 24At €6.85, Is It Time To Put Osmozis SA (EPA:ALOSM) On Your Watch List?While Osmozis SA ( EPA:ALOSM ) might not be the most widely known stock at the moment, it received a lot of attention...Price Target Changed • Jan 14Price target increased to €9.50Up from €8.00, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €7.65. Stock is up 39% over the past year. The company is forecast to post earnings per share of €1.07 for next year compared to €0.46 last year.Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 22% share price gain to €8.20, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 24x in the Communications industry in Europe. Total returns to shareholders of 10% over the past three years.分析記事 • Dec 28Investors Shouldn't Be Too Comfortable With Osmozis' (EPA:ALOSM) Robust EarningsLast week's profit announcement from Osmozis SA ( EPA:ALOSM ) was underwhelming for investors, despite headline numbers...分析記事 • Dec 25Is Osmozis (EPA:ALOSM) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • Dec 24Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: €0.46 (up from €0.92 loss in FY 2020). Revenue: €10.0m (up 21% from FY 2020). Net income: €990.4k (up €2.96m from FY 2020). Profit margin: 9.9% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 100%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 22%, compared to a 21% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.Reported Earnings • Dec 24Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: €0.46 (up from €0.92 loss in FY 2020). Revenue: €10.0m (up 21% from FY 2020). Net income: €990.4k (up €2.96m from FY 2020). Profit margin: 9.9% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 100%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 22%, compared to a 21% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.Price Target Changed • Oct 13Price target increased to €8.00Up from €6.70, the current price target is provided by 1 analyst. New target price is 40% above last closing price of €5.70. Stock is up 6.5% over the past year.分析記事 • Jun 13Is Osmozis (EPA:ALOSM) Using Debt In A Risky Way?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Reported Earnings • Jun 05First half 2021 earnings released: €0.22 loss per share (vs €0.52 loss in 1H 2020)The company reported a decent first half result with reduced losses and improved control over expenses, although revenues were flat. First half 2021 results: Revenue: €3.11m (flat on 1H 2020). Net loss: €479.0k (loss narrowed 57% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 14% per year.分析記事 • Feb 28How Is Osmozis' (EPA:ALOSM) CEO Paid Relative To Peers?Gérard Tremblay has been the CEO of Osmozis SA ( EPA:ALOSM ) since 2016, and this article will examine the executive's...分析記事 • Jan 05Is Osmozis (EPA:ALOSM) Likely To Turn Things Around?If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Is New 90 Day High Low • Dec 31New 90-day high: €6.50The company is up 19% from its price of €5.45 on 02 October 2020. The French market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is up 8.0% over the same period.Valuation Update With 7 Day Price Move • Dec 31Investor sentiment improved over the past weekAfter last week's 15% share price gain to €6.50, the stock is trading at a trailing P/E ratio of 40.1x, up from the previous P/E ratio of 34.8x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 19%.Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 20% share price gain to €5.75, the stock is trading at a trailing P/E ratio of 35.4x, up from the previous P/E ratio of 29.6x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 36%.Valuation Update With 7 Day Price Move • Oct 19Market pulls back on stock over the past weekAfter last week's 16% share price decline to €5.05, the stock is trading at a trailing P/E ratio of 31.1x, down from the previous P/E ratio of 37x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 45%.Is New 90 Day High Low • Oct 19New 90-day low: €5.05The company is down 27% from its price of €6.95 on 21 July 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Communications industry, which is up 11% over the same period.Is New 90 Day High Low • Sep 23New 90-day low: €5.30The company is down 28% from its price of €7.35 on 25 June 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Communications industry, which is up 18% over the same period.決済の安定と成長配当データの取得安定した配当: ALOSMの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: ALOSMの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Osmozis 配当利回り対市場ALOSM 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (ALOSM)n/a市場下位25% (FR)2.0%市場トップ25% (FR)5.7%業界平均 (Communications)1.5%アナリスト予想 (ALOSM) (最長3年)n/a注目すべき配当: ALOSMは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: ALOSMは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: ALOSMの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: ALOSMが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YFR 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/08/12 16:25終値2024/08/12 00:00収益2024/02/29年間収益2023/08/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Osmozis SA 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Christian DevismesCIC Market Solutions (ESN)Thomas CoudryStifel, formerly Bryan GarnierEric LemarieStifel, formerly Bryan Garnier
New Risk • Jun 11New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.6% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€43.0m market cap, or US$46.2m).
New Risk • May 30New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 54% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks High level of debt (54% net debt to equity). Profit margins are more than 30% lower than last year (6.7% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€42.9m market cap, or US$46.4m).
New Risk • May 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.5% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€42.3m market cap, or US$45.9m).
Reported Earnings • Jan 02Full year 2023 earnings released: EPS: €0.29 (vs €0.47 in FY 2022)Full year 2023 results: EPS: €0.29 (down from €0.47 in FY 2022). Revenue: €13.2m (up 14% from FY 2022). Net income: €701.7k (down 30% from FY 2022). Profit margin: 5.3% (down from 8.7% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.
New Risk • Dec 26New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended February 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks High level of debt (150% net debt to equity). Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Shareholders have been diluted in the past year (34% increase in shares outstanding). Market cap is less than US$100m (€31.4m market cap, or US$34.6m).
お知らせ • Oct 13Osmozis SA (ENXTPA:ALOSM) acquired Campingconnect Ltd.Osmozis SA (ENXTPA:ALOSM) acquired Campingconnect Ltd on October 11, 2023.Osmozis SA (ENXTPA:ALOSM) completed the acquisition of Campingconnect Ltd on October 11, 2023.
分析記事 • Sep 16There's Been No Shortage Of Growth Recently For Osmozis' (EPA:ALOSM) Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...
Reported Earnings • Dec 17Full year 2022 earnings releasedFull year 2022 results: Revenue: €11.6m (up 21% from FY 2021). Net income: €1.01m (up 1.7% from FY 2021). Profit margin: 8.7% (down from 10% in FY 2021). The decrease in margin was driven by higher expenses.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Assistant CEO, Director & Co-Founder Yves Boulot was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Sep 22Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €7.64, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 21x in the Communications industry in France. Total loss to shareholders of 21% over the past three years.
Price Target Changed • Apr 27Price target increased to €9.50Up from €8.30, the current price target is provided by 1 analyst. New target price is 18% above last closing price of €8.06. Stock is up 55% over the past year. The company is forecast to post earnings per share of €1.17 for next year compared to €0.46 last year.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Assistant CEO, Director & Co-Founder Yves Boulot was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
分析記事 • Jan 24At €6.85, Is It Time To Put Osmozis SA (EPA:ALOSM) On Your Watch List?While Osmozis SA ( EPA:ALOSM ) might not be the most widely known stock at the moment, it received a lot of attention...
Price Target Changed • Jan 14Price target increased to €9.50Up from €8.00, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €7.65. Stock is up 39% over the past year. The company is forecast to post earnings per share of €1.07 for next year compared to €0.46 last year.
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 22% share price gain to €8.20, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 24x in the Communications industry in Europe. Total returns to shareholders of 10% over the past three years.
分析記事 • Dec 28Investors Shouldn't Be Too Comfortable With Osmozis' (EPA:ALOSM) Robust EarningsLast week's profit announcement from Osmozis SA ( EPA:ALOSM ) was underwhelming for investors, despite headline numbers...
分析記事 • Dec 25Is Osmozis (EPA:ALOSM) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • Dec 24Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: €0.46 (up from €0.92 loss in FY 2020). Revenue: €10.0m (up 21% from FY 2020). Net income: €990.4k (up €2.96m from FY 2020). Profit margin: 9.9% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 100%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 22%, compared to a 21% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
Reported Earnings • Dec 24Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: €0.46 (up from €0.92 loss in FY 2020). Revenue: €10.0m (up 21% from FY 2020). Net income: €990.4k (up €2.96m from FY 2020). Profit margin: 9.9% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 100%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 22%, compared to a 21% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
Price Target Changed • Oct 13Price target increased to €8.00Up from €6.70, the current price target is provided by 1 analyst. New target price is 40% above last closing price of €5.70. Stock is up 6.5% over the past year.
分析記事 • Jun 13Is Osmozis (EPA:ALOSM) Using Debt In A Risky Way?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Reported Earnings • Jun 05First half 2021 earnings released: €0.22 loss per share (vs €0.52 loss in 1H 2020)The company reported a decent first half result with reduced losses and improved control over expenses, although revenues were flat. First half 2021 results: Revenue: €3.11m (flat on 1H 2020). Net loss: €479.0k (loss narrowed 57% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 14% per year.
分析記事 • Feb 28How Is Osmozis' (EPA:ALOSM) CEO Paid Relative To Peers?Gérard Tremblay has been the CEO of Osmozis SA ( EPA:ALOSM ) since 2016, and this article will examine the executive's...
分析記事 • Jan 05Is Osmozis (EPA:ALOSM) Likely To Turn Things Around?If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Is New 90 Day High Low • Dec 31New 90-day high: €6.50The company is up 19% from its price of €5.45 on 02 October 2020. The French market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is up 8.0% over the same period.
Valuation Update With 7 Day Price Move • Dec 31Investor sentiment improved over the past weekAfter last week's 15% share price gain to €6.50, the stock is trading at a trailing P/E ratio of 40.1x, up from the previous P/E ratio of 34.8x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 19%.
Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 20% share price gain to €5.75, the stock is trading at a trailing P/E ratio of 35.4x, up from the previous P/E ratio of 29.6x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 36%.
Valuation Update With 7 Day Price Move • Oct 19Market pulls back on stock over the past weekAfter last week's 16% share price decline to €5.05, the stock is trading at a trailing P/E ratio of 31.1x, down from the previous P/E ratio of 37x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 45%.
Is New 90 Day High Low • Oct 19New 90-day low: €5.05The company is down 27% from its price of €6.95 on 21 July 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Communications industry, which is up 11% over the same period.
Is New 90 Day High Low • Sep 23New 90-day low: €5.30The company is down 28% from its price of €7.35 on 25 June 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Communications industry, which is up 18% over the same period.